Moderna Files for Clearance of Covid Vaccine in Adolescents

June 10, 2021, 1:32 PM

Moderna Inc. filed for U.S. emergency-use authorization of its Covid-19 vaccine in adolescents, a move that would further expand access to the pandemic preventive.

Authorization by the U.S. Food and Drug Administration would make it the second vaccine approved for this age group. Pfizer Inc. and partner BioNTech SE received authorization for use of their shot in teens in May. Both vaccines are now being studied in younger children.

Medtronic has already filed for authorization in Canada and Europe and will file with regulators around the world for clearance in the adolescent age group, Chief Executive Officer Stephane Bancel said ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.